✦ LIBER ✦

Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy

✍ Scribed by V Sánchez; J.F Delgado; T Blasco; R Dalmau; J.M Morales; P Escribano; R Tello; J Hernández; T Velázquez; T Sotelo; M.A Gómez-Sánchez; C Sáenz de la Calzada

Book ID: 117238347
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 52 KB
Volume: 31
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(99)00442-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of mycophenolate-mofetil (MMF) i

Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation

✍ A. Zuckermann; M. Ploner; Ü. Keziban; M. Czerny; E. Wolner; G. Laufer; M. Grimm 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Benefit of mycophenolate mofetil in pati

Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation

✍ A Zuckermann; T Birsan; S Thaghavi; N Kupilik; E Deviatko; G Dekan; E Wolner; W 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Elective withdrawal of mycophenolate mof

Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone

✍ C. G. ter Meulen; L. B. Hilbrands; P. J. H. Smak Gregoor; W. Weimar 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 378 KB

Elective withdrawal of mycophenolate mof

Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone

✍ Cornelis G. ter Meulen; Peter J. H. Smak Gregoor; Willem Weimar; Luuk B. Hilbran 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 49 KB

Mycophenolate mofetil overlap in liver t

Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity

✍ J Torras; J Figueras; C Lama; J Fabregat; E Ramos; A Rafecas; S Gil-Vernet; D Pa 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Pharmacokinetics of mycophenolate mofeti

Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine

✍ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req